About SiVEC Biotechnologies
SiVEC Biotechnologies is a Healthcare company based in Fort Collins (United States) founded in 2016 by Darcy Mora and Lyndsey Linke. Antiviral products are developed using patent-pending technology for disease prevention. SiVEC Biotechnologies has raised $3.3 million across 4 funding rounds from investors including HHS. Its chief executive, as recorded, is Lyndsey Linke. SiVEC Biotechnologies offers products and services including BactPac. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Viral. Its competitors include Adaptive Biotechnologies, Moderna and Avidity Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
SiVEC Biotechnologies was founded in 2016 in Fort Collins, United States, within the biotechnology sector. Antiviral solutions are created by the company to address economically significant diseases, particularly in poultry. The SiVEC-AIV technology, which is patent-pending, targets and eliminates avian flu viruses. Applications are delivered via aerosol or drinking water to treat over 20,000 birds efficiently. This platform is also adapted for other animal and human diseases.
- Headquarters Fort Collins, United States
- Founders Darcy Mora, Lyndsey Linke
- SectorsHealthcare
- Email••••••••
- Website sivecbiotechnologies.com
- Total Equity Funding$3.3M (USD)
in 4 rounds
- Latest Funding Round$3.3M (USD), Series A
Aug 2025
- Investors
Products & Services of SiVEC Biotechnologies
SiVEC Biotechnologies offers a comprehensive portfolio of products and services, including BactPac.
Engineered bacteria for safe and precise therapeutic payload delivery.
Funding Insights of SiVEC Biotechnologies
SiVEC Biotechnologies has successfully raised a total of $3.3M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $3.3 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.3M
- Total Rounds 4
- Last Round Series A — $3.3M
- First Round $3.34M
(Aug 2018)
- Investors Count 1
All 4 funding rounds of SiVEC Biotechnologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in SiVEC Biotechnologies
SiVEC Biotechnologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for SiVEC Biotechnologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SiVEC Biotechnologies
2 people are tracked at SiVEC Biotechnologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Darcy Mora | Co-Founder | Leadership |
Lyndsey Linke | Co-Founder & CEO | Leadership |
Complete people profiles for SiVEC Biotechnologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SiVEC Biotechnologies
3 dated milestones of SiVEC Biotechnologies across 9 years, from founding to its latest funding, stage changes and deals.
- Founded SiVEC Biotechnologies is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Series A, of $3.3M.
Competitors of SiVEC Biotechnologies
SiVEC Biotechnologies has 3 listed competitors in our database, 3 of them funded. They include Adaptive Biotechnologies, Moderna and Avidity Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adaptivebiotech.com | 2009 | Seattle, United States | $419.15M | 609 | Clinical diagnostics and drug discovery for immune diseases are provided. | |
| modernatx.com | 2010 | Cambridge, United States | $2.78B | 1,312 | mRNA-based therapeutics for diseases including cancer and infections are developed. | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. |
Detailed competitors of SiVEC Biotechnologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as SiVEC Biotechnologies (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sivec Biotechnologies
Complete news archive for SiVEC Biotechnologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SiVEC Biotechnologies
SiVEC Biotechnologies was founded in 2016 and raised its 1st funding round 2 years after it was founded.
SiVEC Biotechnologies is headquartered in Fort Collins, United States. It is registered at Fort Collins, Colorado, United States.
Lyndsey Linke is the CEO of SiVEC Biotechnologies, as recorded in our data. They have also founded this company.
SiVEC Biotechnologies is a funded company, having raised a total of $3.3M across 4 funding rounds to date. The company's 1st funding round was a Grant of $3.34M, raised on Aug 2018.
SiVEC Biotechnologies was founded in 2016 in Fort Collins, United States, within the biotechnology sector. Antiviral solutions are created by the company to address economically significant diseases, particularly in poultry. The SiVEC-AIV technology, which is patent-pending, targets and eliminates avian flu viruses. Applications are delivered via aerosol or drinking water to treat over 20,000 birds efficiently. This platform is also adapted for other animal and human diseases.
SiVEC Biotechnologies's top competitors include Moderna, Adaptive Biotechnologies and Avidity Biosciences.
SiVEC Biotechnologies offers BactPac.
SiVEC Biotechnologies has 1 investor. Key investors include HHS.